APA (7th ed.) Citation

T, A., P, L., S, A., M, B., A, S., P, B., . . . H, W. (2025). Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48. Liver international : official journal of the International Association for the Study of the Liver, 45(4), e16174. https://doi.org/10.1111/liv.16174

Chicago Style (17th ed.) Citation

T, Asselah, et al. "Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48." Liver International : Official Journal of the International Association for the Study of the Liver 45, no. 4 (2025): e16174. https://doi.org/10.1111/liv.16174.

MLA (9th ed.) Citation

T, Asselah, et al. "Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48." Liver International : Official Journal of the International Association for the Study of the Liver, vol. 45, no. 4, 2025, p. e16174, https://doi.org/10.1111/liv.16174.